The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres

被引:107
作者
Kiliçarslan, M [1 ]
Baykara, T [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
verapamil HCl; Eudragit RS 100; microsphere; solvent evaporation method;
D O I
10.1016/S0378-5173(02)00630-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, the microspheres containing verapamil hydrochloride (VRP) were prepared with Eudragit RS 100 by solvent evaporation method. In the solvent evaporation method one of the parameters which affect to the formation and properties of the microspheres is the variations of drug/polymer ratios. The aim of our study is to examine the effects of this parameter on the VRP loaded microspheres. To achieve this purpose, only drug/polymer ratio was altered while the other formulation parameters were kept constant and percentage yield value, incorporation efficiency, particle size and distribution of the microspheres were analyzed and micrographs of the microspheres were taken to determine the effects of the increase in the polymer amount of formulations. All the dispersed phase viscosities were evaluated by comparing them with the variations in particle size and distribution of the microspheres. In vitro dissolution tests were done by using dissolution media with three different pH in sequence as half-change method with flow through cell and the effect of the variation in polymer ratio on drug dissolution was evaluated according to dissolution test results. As a result of our study, it is thought that the variation in drug/polymer ratios might have an influence on the physical characteristics of the microspheres and the increasing amount of polymer might be result in decreased drug dissolve. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 109
页数:11
相关论文
共 35 条
[1]   Preparation and evaluation of sustained-release solid dispersions of drugs with Eudragit polymers [J].
Ammar, HO ;
Khalil, RM .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (11) :1043-1054
[2]  
BENOIT JP, 1996, MICROENCAPSULATION M, P35
[3]   EFFECT OF VARYING DRUG LOADING ON PARTICLE-SIZE DISTRIBUTION AND DRUG-RELEASE KINETICS OF VERAPAMIL HYDROCHLORIDE MICROSPHERES PREPARED WITH CELLULOSE ESTERS [J].
BHARDWAJ, SB ;
SHUKLA, AJ ;
COLLINS, CC .
JOURNAL OF MICROENCAPSULATION, 1995, 12 (01) :71-81
[4]   EUDRAGIT-E MICROSPHERES CONTAINING BACAMPICILLIN - PREPARATION BY SOLVENT REMOVAL METHODS [J].
BOGATAJ, M ;
MRHAR, A ;
KRISTL, A ;
KOZJEK, F .
JOURNAL OF MICROENCAPSULATION, 1991, 8 (03) :401-406
[5]   FORMULATION, PREPARATION AND DISSOLUTION CHARACTERISTICS OF PROPRANOLOL HYDROCHLORIDE MICROSPHERES [J].
CHIAO, CSL ;
PRICE, JC .
JOURNAL OF MICROENCAPSULATION, 1994, 11 (02) :153-159
[6]   SUPERIORITY OF STABLE ISOTOPE TECHNIQUES IN THE ASSESSMENT OF THE BIOAVAILABILITY OF DRUGS UNDERGOING EXTENSIVE 1ST PASS ELIMINATION - STUDIES OF THE RELATIVE BIOAVAILABILITY OF VERAPAMIL TABLETS [J].
EICHELBAUM, M ;
DENGLER, HJ ;
SOMOGYI, A ;
VONUNRUH, GE .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 19 (02) :127-131
[7]   PHARMACOKINETICS OF CONVENTIONAL AND SLOW-RELEASE VERAPAMIL [J].
FOLLATH, F ;
HA, HR ;
SCHUTZ, E ;
BUHLER, F .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 :S149-S153
[8]  
FOLLONIER N, 1992, STP PHARMA SCI, V2, P141
[9]   ESTABLISHMENT OF SINK CONDITIONS IN DISSOLUTION RATE DETERMINATIONS - THEORETICAL CONSIDERATIONS AND APPLICATION TO NONDISINTEGRATING DOSAGE FORMS [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1967, 56 (10) :1238-&
[10]   PHYSICAL CHARACTERIZATION AND DISSOLUTION PROPERTIES OF VERAPAMIL.HCL COPRECIPITATES [J].
GORACINOVA, K ;
KLISAROVA, L ;
SIMOV, A .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (03) :383-391